Obstetrics, gynecology and reproductive medicine guidelines

Anemia and hemoglobinopathies

PubMed Free Full Text

Anemia in cancer

Canada

• Cancer Care Ontario
  • Treatment for anemia with erythropoietic agents in patients with non-myeloid hematological malignancies: a clinical practice guideline [2007]
  • The role of erythropoietin in the managment of cancer patients with non-hematologic malignancies receiveing chemotherapy [2005]

Europe

• European Society for Medical Oncology
  • Erythropoiesis-stimulating agents in cancer patients: ESMO Recommendations for use [2009]

International

• Cochrane Library
  • Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data

United Kingdom

• Health Technology Assessment
  • A systematic review and economic evaluation of epoetin alfa, epoetin beta and darbepoetin alfa in anaemia associated with cancer, especially that attributable to cancer treatment [2007]

• National Institute for Health and Clinical Excellence
  • Anaemia (cancer-treatment induced) - erythropoietin (alpha and beta) and darbepoetin [2008]

• NHS Quality Improvement Scotland
  • NICE (Multiple) Technology Appraisal Guidance No 142 – Epoetin alfa, epoetin beta and darbepoetin alfa for cancer treatment-induced anaemia [2008]

United States of America

• Agency for Healthcare Research and Quality
  • Uses of Epoetin for Anemia in Oncology [2001]

• American Society of Clinical Oncology
  • Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology [2002]

• National Guideline Clearinghouse
  • Epoetin alfa, epoetin beta and darbepoetin alfa for cancer treatment-induced anaemia. National Institute for Health and Clinical Excellence (NICE) [2008]
  • Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update [2007]
  • Treatment for anemia with erythropoietic agents in patients with non-myeloid hematological malignancies: a clinical practice guideline. Program in Evidence-based Care [2007]
  • The role of erythropoietin in the management of cancer patients with non-hematologic malignancies receiving chemotherapy. Cancer Care Ontario [2005]

Articles in journals

• Annals of Oncology
  • Recombinant human erythropoietin in oncology: current status and further developments [2005]
  • Management of anaemia in patients with breast cancer: role of epoetin [2005]
  • Application and safety of erythropoietin in cancer management [2005]

• Hematology
  • Erythropoietin: A Paradigm for the Development of Practice Guidelines [2001]

• Journal of the National Cancer Institute
  • Recombinant Human Erythropoietins and Cancer Patients: Updated Meta-Analysis of 57 Studies Including 9353 Patients [2006]
  • Recombinant Human Erythropoietin and Overall Survival in Cancer Patients: Results of a Comprehensive Meta-analysis [2005]

• Nephrology Dialysis Transplantation
  • Cancer-related anaemia requires higher doses of epoetin alfa than chronic renal failure replacement therapy [2001]

{Related topics}

• Guidelines
  • Anemia